Skip to main content

BriaCell Therapeutics Corp. (BCTX)

NASDAQ: BCTX · IEX Real-Time Price · USD
7.82 0.18 (2.36%)
Oct 26, 2021 2:06 PM EDT - Market open

Income Statement (Annual)

Financials in millions USD. Fiscal year is August - July.
Year202020192018
Selling, General & Admin
1.861.241.39
Research & Development
2.984.923.11
Other Operating Expenses
00.060.48
Operating Expenses
4.846.224.98
Operating Income
-4.84-6.22-4.98
Interest Expense / Income
0.040.030.02
Other Expense / Income
0.07-0.460.42
Pretax Income
-4.94-5.79-5.41
Net Income
-4.94-5.79-5.41
Net Income Common
-4.94-5.79-5.41
Shares Outstanding (Basic)
110
Shares Outstanding (Diluted)
110
Shares Change
23.16%35.49%-
EPS (Basic)
-6.99-10.02-0.04
EPS (Diluted)
-6.99-10.02-0.04
Free Cash Flow Per Share
-2.18-8.79-11.59
EBITDA
-4.89-5.74-5.38
EBIT
-4.91-5.76-5.39
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).